Skip to content
For three decades, Genethon, a non-profit research organization, has pioneered development of gene therapies for rare and ultra-rare diseases. Now that our hard work […]
A significant increase in the percentage of Shigella infections caused by extensively drug-resistant (XDR) versions of the bacteria has prompted the U.S. Centers for
The rise of drug-resistant Shigella offers glimpse into danger AMR poses Read More »
The U.S. Department of Agriculture (USDA) held the 99th Agricultural Outlook Forum last week, where many speakers highlighted the potential of biotechnology and bio-based products.
USDA Agricultural Outlook Forum: SAF, carbon markets, and the future of biotechnology Read More »
According to a recent report from IQVIA, the market for biosimilars, which mimic innovative biologics, is poised to grow this year. Since 2007, a
Biosimilars expected to boom in 2023-27, says report Read More »
Starting Veklury (remdesivir) within the first two days of hospitalization for COVID-19 can reduce mortality and decrease readmission rates for all hospitalized patients, regardless
Gilead’s anti-COVID Veklury reduces risk of death Read More »
Pfizer’s vaccine aimed at protecting infants against severe respiratory syncytial virus (RSV) could roll out as early as this summer as the Food and
Pfizer’s RSV vaccine for infants could be approved this summer Read More »
Biotechnology Innovation Organization (BIO) member Acceligen partnered with the USDA’s Agricultural Research Service to develop gene-edited cattle resistant to bovine viral diarrhea (BVD), a
Acceligen’s gene-edited calf less susceptible to BVDV Read More »
“You know,” Karyne Jones laughs, “I am about the same age as many of the people I work with, so the older I get,
NCBA understands that, in Black America, health care is holistic Read More »
A California biotech company seeking to help fight climate change is using the power of plants to create a new tool for that fight:
Biotech helps to fight climate change with carbon-devouring GM trees Read More »
When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still
BIO’s long COVID webinar furthers search for biotech solutions Read More »
